Your browser doesn't support javascript.
loading
Simplified Test-to-Treat Strategy for Hepatitis C in Thailand: The Phetchabun Model.
Wasitthankasem, Rujipat; Wanlapakorn, Nasamon; Pimsing, Napaporn; Posuwan, Nawarat; Poovorawan, Yong.
Afiliação
  • Wasitthankasem R; National Biobank of Thailand, National Science and Technology Development Agency, Pathum Thani, Thailand.
  • Wanlapakorn N; Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Patum Thani, Thailand.
  • Pimsing N; Phetchabun Provincial Public Health Office, Phetchabun, Thailand.
  • Posuwan N; Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Patum Thani, Thailand.
  • Poovorawan Y; Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Patum Thani, Thailand.
J Infect Dis ; 228(Suppl 3): S198-S203, 2023 09 13.
Article em En | MEDLINE | ID: mdl-37703343
ABSTRACT
The complexity of the hepatitis C virus (HCV) diagnostic workflow and stringent criteria for universal health coverage are significant barriers to achieving HCV elimination in Thailand. A test-to-treat strategy using a rapid diagnostic test (RDT) for screening at point of care, followed by a qualitative nucleic acid testing, is a promising strategy to facilitate population-wide screening for HCV infection and expedite time to treatment. This strategy was evaluated in Phetchabun province, Thailand, where the HCV burden is relatively high. This simplified HCV test-to-treat strategy showed strong potential to be implemented at a national level. Several obstacles to implementation included the stringent criteria for universal health coverage, which prioritizes patients with advanced disease, the continuous policy revision for HCV treatment and care, the relatively low public awareness of HCV infection, and the lagging of government policy prioritization. All of these contribute to the delayed progress in hepatitis elimination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepatite A Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepatite A Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article